Home | Welcome to Contract Pharma   
Last Updated Saturday, December 20 2014

Print

Breaking News

Kristin Brooks
December 13, 2013
Rezac brings international experience   Read More »
Gil Roth
December 13, 2013
Astellas, Auxilum, Aveo, Celsion, Genzyme, Janssen, Sanofi, Tekmira, VG Life Sciences  Read More »
Kristin Brooks
December 13, 2013
Gluck to lead clinical trial programs  Read More »
Gil Roth
December 12, 2013
Hisamitsu, ImmunoCellular Therapeutics, Kyowa Hakko Kirin, Lupin, Mallinckrodt, Medivir, Naurex, Orexo, Synta  Read More »
Kristin Brooks
December 12, 2013
To provide R&D process development and API manufacturing  Read More »
Kristin Brooks
December 12, 2013
Franken to oversee operational management of biosimilars program  Read More »
Kristin Brooks
December 12, 2013
Evangelista to lead global commercial organization  Read More »
Kristin Brooks
December 12, 2013
Moore and Stanley to pursue other opportunities  Read More »
Kristin Brooks
December 12, 2013
Will work to identify predictive biomarkers in drug-resistant tumors  Read More »
Kristin Brooks
December 12, 2013
To obtain large numbers of cells for Nuvilex's pancreatic cancer trials  Read More »
Kristin Brooks
December 12, 2013
Facklam brings 30 years of clinical drug development experience  Read More »
Kristin Brooks
December 12, 2013
Expands manufacturing capabilities with fill/finish business in $222 million buy  Read More »
Gil Roth
December 11, 2013
AbbVie, Avanir, Baxter, Genzyme, KaloBios, Merck, Orexigen, QRxPharma, Seattle Genetics  Read More »
Kristin Brooks
December 11, 2013
To use Potelligent CHOK1SV in pipeline of multiple antibodies   Read More »
Kristin Brooks
December 11, 2013
Will conduct trials with Bayer’s investigational anti-cancer agents  Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On